Gland Pharma

Rediff.com » News » Gland Pharma

News for Gland Pharma

News
Business

Russia reaches out to Kerala for Sputnik V plant

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms......

'Sputnik V provides immunity for a longer duration'

'Its efficacy is 97.6 per cent.' Morepen India Chairman and Managing Director Sushil Suri in an interview with Uddalok Bhattacharya says the Sputnik V vaccine it is manufacturing in India......

India to produce 850mn Sputnik doses annually: RDIF

The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has also given approval for the emergency......

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

As more and more states flag shortage of COVID-19 vaccine doses, the Central government has pressed the accelerator to scale up vaccine production manifold. Top government sources said that by end......

Sputnik V vaccine may be added to India's Covid armoury soon

‘We expect to get the approval in the next few weeks,’ says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL). IMAGE: Medics administer the first......

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. Gland Pharma's......

Buy mid, small-caps selectively, say analysts

After a sharp outperformance in the mid-and small-cap segments in the first half of calendar year 2023 (H1-CY23), analysts are now turning cautious on these two market segments and suggest......

NSE to include Adani Wilmar, Adani Power to few indices from Mar 31

Leading stock exchange NSE has tweaked the constituents of its major indices with Adani Group's two companies -- Adani Wilmar and Adani Power -- all set to make their way into some of the Nifty......

Key mantra for India's pharma sector in 2023

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......

2022: Be Choosy About Stocks

So which sectors are likely to do well in 2022?Should you focus on domestic economy-related sectors or export-oriented ones? Illustration: Dominic Xavier/Rediff.com Dalal Street witnessed a......

Rediff News

Gland Pharma

News for Gland Pharma

Russia reaches out to Kerala for Sputnik V plant

'Sputnik V provides immunity for a longer duration'

India to produce 850mn Sputnik doses annually: RDIF

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

Sputnik V vaccine may be added to India's Covid armoury soon

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Buy mid, small-caps selectively, say analysts

NSE to include Adani Wilmar, Adani Power to few indices from Mar 31

Key mantra for India's pharma sector in 2023

2022: Be Choosy About Stocks

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS